Advances in diagnostics, therapeutics, and devices are revolutionizing the management of respiratory and allergy conditions. New classes of inhaled and injected biologic therapies offer new promise for poorly managed asthma and COPD patients. Scientific and diagnostic advances are providing insights into previously underdiagnosed patient segments and phenotypes with high unmet needs. New drug delivery devices and connected digital health solutions are providing new levels of outcomes and population management potential for both innovative and long proven therapies. Health Advances’ breadth of expertise in the clinical and commercial aspects of the biopharmaceutical market position us to be your best partner for success.

Health Advances' disease breadth along with device and drug delivery knowledge arms us to develop pragmatic approaches to address the challenges of diagnosing and treating respiratory and allergy conditions. Indications in which Health Advances has expertise include:
  • Acute Respiratory Distress Syndrome
  • Allergic Rhinitis
  • Alpha-1 Antitrypsin Deficiency
  • Anaphylaxis
  • Asthma
  • Atopic Dermatitis
  • Beryllium Disease
  • Bronchiectasis
  • Bronchitis
  • Bronchopulmonary Dysplasia
  • Chronic Obstructive Pulmonary Disease
  • COPD, Chronic Bronchitis, Emphysema
  • Cystic Fibrosis (CF)
  • Emphysema
  • Food Allergies
  • Granuloma
  • Idiopathic Pulmonary Fibrosis
  • Interstitial Lung Diseases
  • Lung Cancer
  • Lung Reduction Surgery
  • Nontuberculous Mycobacteria (NTM)
  • Pulmonary Arterial Hypertension
  • Pulmonary Fibrosis
  • Pulmonary Hypertension
  • Respiratory Syncytial Virus
  • Sarcoidosis
  • SARS
  • Secondary Pulmonary Hypertension
  • SIDS
  • Sinusitis
  • Stevens-Johnson Syndrome
  • Tuberculosis
  • Ventilator Acquired Pneumonia (VAP)

View our respiratory and allergy conditions case examples.